pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

Trump health-care czar touts $510 billion Medicaid cut, warns hospitals of financial strain

Jun 9, 2026·read at STAT ↗RegulatoryNegative

At a Healthcare Financial Management Association conference in National Harbor, Maryland, the Trump administration’s newly appointed health-care affordability czar addressed hospital finance leaders.

Casey Mulligan, the Department of Health and Human Services’ chief economist and chief regulatory officer, used the platform to promote the One Big Beautiful Bill Act, which proposes cuts to state-directed Medicaid payments projected to save about $510 billion over the next decade.

Hospital executives warned that the reductions, which would lower the payments they receive from Medicaid and affect the federal match, could strain their finances and make it harder to maintain services.

The administration argues the cuts will improve affordability and reduce federal spending, while the health-care industry anticipates challenges in adapting to the reduced revenue streams.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders”

read at STAT ↗
558 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7NOVOPFIZER
topics
Vaccines

related stories

  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 5STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and moreSTAT
  • Aug 26Inside the Gulf biotech deal model, ahead of RGMBS 2026 in RiyadhBioSpace
  • Aug 4Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructureBioSpace
  • Jul 23Chutes & Ladders—Biogen R&D vet gets in FormationFierce Biotech